Comments on: Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer

Comments on: Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer /geneseeq-published-new-research-on-the-clinical-use-of-circulating-free-dna-fragmentomic-in-monitoring-minimal-residual-disease-for-patients-with-non-small-cell-lung-cancer/ We see precision medicine as the future of cancer care. Let’s accelerate precision cancer care, together. Wed, 28 May 2025 19:25:38 +0000 hourly 1 https://wordpress.org/?v=6.9.4